Axicabtagene ciloleucel in R/R LBCL in Saudi Arabia: a cost-effectiveness and treatment misallocation analysis

Blood Global Hematology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles